Which cytochrome P450 isoenzymes metabolize clozapine?

The provided sources do not specify which cytochrome P450 isoenzymes metabolize clozapine, stating only that it is metabolized in the liver into inactive metabolites.

What is the main difference between Clozapine and other neuroleptics regarding motor function?

Extrapyramidal symptoms occur very rarely with this drug—in approximately 1% of cases—and it does not cause pronounced psychomotor slowing.

Which receptors does Clozapine block?

The drug blocks D₄ receptors (with high affinity), 5-HT₂A receptors, muscarinic cholinergic receptors, and α₁-adrenergic receptors.

What is the most dangerous side effect described for this medication?

The most dangerous are hematological adverse effects: bone marrow suppression leading to granulocytopenia and the risk of developing agranulocytosis.

What specific autonomic phenomenon accompanies the use of the drug?

A characteristic side effect is hypersalivation (excessive drooling), along with atropine-like symptoms and orthostatic hypotension.

Home › Pharmacology › Clozapine

Clozapine

Clozapinum

For medical students2 min readUpdated 2026-10-10

Clozapine is a high-potency atypical antipsychotic drug belonging to the dibenzodiazepine derivative class. It possesses strong sedative properties, effectively manages psychiatric symptoms, and is notable for an extremely low incidence of extrapyramidal symptoms.

Drug ClassDibenzodiazepine derivative (Atypical antipsychotic)

Extrapyramidal EffectsExtremely rare — occurs in about 1% of cases

Protein BindingHigh, up to 95% in blood plasma

Half-lifeApproximately 12 hours

Major RiskRisk of granulocytopenia and agranulocytosis

Pharmacodynamics and Mechanism of Action

This medication features a unique receptor activity profile. The drug primarily blocks D₄ receptors, exhibiting a higher affinity for them than for D₂ receptors. In addition, its pharmacological effects stem from the blockade of 5-HT₂A receptors, as well as muscarinic (M) cholinergic receptors and α₁-adrenergic receptors.

Due to this profile, the agent successfully addresses the manifestations of schizophrenia. Unlike many conventional neuroleptics, the drug effectively treats not only positive but also negative symptoms: emotional flattening, introversion, and poverty of speech. Furthermore, therapy is not accompanied by general psychomotor slowing, and unwanted motor disorders are documented in only a handful of patients.

Pharmacokinetic Properties

The behavior of Clozapine in the body is characterized by the following parameters:

Absorption: Occurs rapidly and nearly completely from the gastrointestinal tract.
Distribution: Body tissues are rapidly saturated; the drug easily crosses the blood-brain barrier (BBB).
Protein binding: Plasma protein binding is high, reaching 95%.
Biotransformation: Breakdown of active components occurs in hepatic tissue, yielding inactive metabolites.
Elimination: The elimination half-life (t½) is approximately 12 hours.

Indications for Use

Clinical application of the medication is focused in psychiatry. The primary diagnoses for which the drug is indicated include:

Treatment-resistant schizophrenia across all its forms and manifestations.
Manic episodes occurring within bipolar disorder (manic-depressive psychosis).

Adverse Reactions and Precautions

The administration of this medication requires rigorous medical supervision due to a broad spectrum of adverse effects:

Hematological system: The most dangerous complication is granulocytopenia with a risk of progressing to agranulocytosis. This necessitates mandatory and regular complete blood count monitoring.
Autonomic and cardiovascular systems: Tachycardia, orthostatic hypotension, atropine-like effects (constipation, accommodation disturbances), and marked hypersalivation (excessive drooling) may occur.
General symptoms: Patients frequently report somnolence, muscle weakness, and increased appetite leading to weight gain.

Frequently asked questions

Which cytochrome P450 isoenzymes metabolize clozapine?: The provided sources do not specify which cytochrome P450 isoenzymes metabolize clozapine, stating only that it is metabolized in the liver into inactive metabolites.
What is the main difference between Clozapine and other neuroleptics regarding motor function?: Extrapyramidal symptoms occur very rarely with this drug—in approximately 1% of cases—and it does not cause pronounced psychomotor slowing.
Which receptors does Clozapine block?: The drug blocks D₄ receptors (with high affinity), 5-HT₂A receptors, muscarinic cholinergic receptors, and α₁-adrenergic receptors.
What is the most dangerous side effect described for this medication?: The most dangerous are hematological adverse effects: bone marrow suppression leading to granulocytopenia and the risk of developing agranulocytosis.
What specific autonomic phenomenon accompanies the use of the drug?: A characteristic side effect is hypersalivation (excessive drooling), along with atropine-like symptoms and orthostatic hypotension.

Go deeper

Receptor interaction mechanisms and affinity for D₂ and D₄ subtypes
Laboratory blood monitoring protocols for the prevention of agranulocytosis
Management of manic states in bipolar disorder
Pharmacokinetic pathways of hepatic metabolism
Correction of autonomic and atropine-like side effects